Wednesday, September 16, 2026Latest filing Sep 14, 2026

David Kustoff Periodic Transaction Report

Filed Nov 30, 2023 · House Clerk · 1 transaction

U.S. Representative · R · TN-08 · All trades by David Kustoff

On November 30, 2023, Rep. David Kustoff (R-TN-08) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Jan 26, 2023.

The filing covers 1 ticker, including $NVDA.

Reported amount ranges sum to $2K–$50K. Congress reports trade sizes in ranges, not exact figures.

1 trade was reported more than 45 days after the trade date, outside the STOCK Act's 45-day window. The longest lag in this filing was 308 days.

Source document: House Clerk filing 8220060

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

David Kustoff · Sold $NVDA · Jan 26 · $2K–$50K

0.33LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.50
Cluster activityx 0.150.30

1 other member traded this name in the same window.

Track recordx 0.350.39

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow David Kustoff

Get an email the moment David Kustoff files the next one. Free, no card, no spam.

Follow free →
1
Transactions
0 / 1
Buys / sells
1
Tickers
308d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Jan 26, 2023NVDANvidia Corp, Common Stocksell$2K–$50K308d

Other recent filings by David Kustoff

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →